04/26/2024 | Press release | Distributed by Public on 04/26/2024 08:10
Improving patient health is the cornerstone of everything we do at Boston Scientific. Whether it's innovating care to help people live longer, better lives; empowering people by advancing diversity, equity and inclusion (DE&I) in our workplace and communities; or enabling a healthier planet - we are committed to making sustainable progress. Our more than 48,000 employees worldwide demonstrate talent and commitment to the highest standards of quality and allow us to raise the bar, year after year.
You can find the latest results of this work documented in our newly released 2023 Performance Report. Read on for a look at some of our biggest accomplishments of the past year.
We help physicians treat more patients more effectively through a global ecosystem of innovation that includes accelerating research and development (R&D), expanding digital platforms to advance care and upholding rigorous quality standards.
How we did in 2023:
We believe people who participate in clinical trials, as well as trial leaders, should demographically reflect the patients who will be helped by the devices being studied - including those who have been historically underrepresented in research.
How we did in 2023:
We're focused on creating a culture that attracts and retains inclusive talent. By 2030, we aspire to improve the gender, race and ethnicity balance of our leadership by focusing on pivotal mid-level roles, including managers, principals, senior managers and fellows, that are a critical feeder pool to senior level roles.
How we did in 2023:
We invest in the development and success of our people through programs and practices that reinforce equitable opportunities for growth, in keeping with our core values.
How we did in 2023:
Since 2017, we have made steady progress to reduce our carbon footprint by cutting energy use, converting to renewable energy sources and compensating for remaining unavoidable emissions with carbon credits and offset projects. We furthered this work in 2022 when we became one of the first companies in the Healthcare Equipment and Supplies sector to have net-zero, science-based scopes 1, 2 and 3 targets approved under the Science Based Targets initiative Net-Zero Standard.
How we did in 2023:
Our commitment to better patient health means we invest in efforts to build a sustainable, resilient business that improves the well-being of our patients, customers, communities and planet.
How we did in 2023:
The path to greater progress takes time. Our commitment to ethical business practices anchors our decisions and ability to deliver value responsibly, providing performance with integrity. In 2023, we continued delivering patient solutions when and where they were needed while further focusing on good governance and compliance, risk management, cybersecurity and a responsible supply chain.
Learn more about how Boston Scientific is advancing science for life through our corporate responsibility strategy.
[1] Represents GAAP R&D expense per Annual Report on Form 10-K.
[2] Mid-level leadership includes managers, principals, senior managers and fellows.
[3] Includes renewable electricity generated onsite and purchased electricity matched with electricity from renewable sources, inclusive of all manufacturing and key distribution sites only.
[4] Percentage of all Boston Scientific real estate (including commercial, leased and owned) that is independently certified for energy efficiency by industry-leading bodies such as LEED for design and Energy Star or ISO 50001:2018 for building operations.